Rezolute's top three insider shareholders as of March 23, 2026 are Young-Jin Kim (Director, 8.42Mn shares), Nevan C Elam (Ceo, 613.50K shares), Daron Evans (Cfo, 404.46K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Young-Jin Kim | 0 | 8,423,386 | 19 Jun, 2025 | |
| Nevan C Elam | Ceo | 613,501 | 0 | 04 Mar, 2026 |
| Daron Evans | Cfo | 404,462 | 0 | 04 Mar, 2026 |
| Brian Kenneth Roberts | Chief Medical Officer | 296,913 | 0 | 04 Mar, 2026 |
| Young-Jin Kim | 170,950 | 0 | 20 Nov, 2025 | |
| Wladimir Hogenhuis | 119,675 | 0 | 17 Dec, 2025 | |
| Sunil Ratilal Karnawat | Chief Commercial Officer | 71,542 | 0 | 15 Dec, 2025 |
| Nerissa Kreher | 58,576 | 0 | 21 Nov, 2025 | |
| Philippe Fauchet | 55,500 | 0 | 20 Nov, 2025 | |
| Gil M Labrucherie | 55,500 | 0 | 20 Nov, 2025 | |
| Gil M Labrucherie | 0 | 53,572 | 09 May, 2022 | |
| Erik Harris | 21,000 | 0 | 20 Nov, 2025 | |
| Daron Evans | Cfo | 0 | 7,000 | 15 Dec, 2025 |
| Brian Kenneth Roberts | Chief Medical Officer | 0 | 1,376 | 14 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Mar, 2026 | Brian Kenneth Roberts | Common Shares | D | 11,439 | $2.99 | 296,913 | D | F |
| 02 Mar, 2026 | Daron Evans | Common Shares | D | 11,438 | $2.99 | 404,462 | D | F |
| 02 Mar, 2026 | Nevan C Elam | Common Shares | D | 27,618 | $2.99 | 613,501 | D | F |
| 16 Dec, 2025 | Wladimir Hogenhuis | Common Shares | A | 5,650 | $1.69 | 119,675 | D | P |
| 16 Dec, 2025 | Brian Kenneth Roberts | Common Shares | A | 28,000 | $1.70 | 308,352 | D | P |
| 15 Dec, 2025 | Daron Evans | Common Shares | A | 40,000 | $1.77 | 415,900 | D | P |
| 15 Dec, 2025 | Nevan C Elam | Common Shares | A | 32,000 | $1.59 | 641,119 | D | P |
| 15 Dec, 2025 | Sunil Ratilal Karnawat | Common Shares | A | 12,000 | $1.62 | 71,442 | D | P |
| 15 Dec, 2025 | Daron Evans | Common Shares | A | 2,500 | $1.79 | 7,000 | I | P |
| 15 Dec, 2025 | Sunil Ratilal Karnawat | Common Shares | A | 100 | $1.60 | 71,542 | D | P |
| 15 Dec, 2025 | Daron Evans | Common Shares | A | 2,500 | $1.79 | 7,000 | I | P |
| 19 Nov, 2025 | Wladimir Hogenhuis | Common Shares | A | 21,000 | $0.00 | 114,025 | D | A |
| 19 Nov, 2025 | Sunil Ratilal Karnawat | Common Shares | A | 32,000 | $0.00 | 59,442 | D | A |
| 19 Nov, 2025 | Nerissa Kreher | Common Shares | A | 21,000 | $0.00 | 58,576 | D | A |
| 19 Nov, 2025 | Daron Evans | Common Shares | A | 107,000 | $0.00 | 375,900 | D | A |
| 19 Nov, 2025 | Brian Kenneth Roberts | Common Shares | A | 123,000 | $0.00 | 280,352 | D | A |
| 19 Nov, 2025 | Nevan C Elam | Common Shares | A | 317,000 | $0.00 | 609,119 | D | A |
| 19 Nov, 2025 | Wladimir Hogenhuis | Director Stock Option (Right to Buy) | A | 12,000 | $0.00 | 12,000 | D | A |
| 19 Nov, 2025 | Nevan C Elam | Employee Stock Option (Right to Buy) | A | 186,000 | $0.00 | 186,000 | D | A |
| 19 Nov, 2025 | Nerissa Kreher | Director Stock Option (Right to Buy) | A | 12,000 | $0.00 | 12,000 | D | A |